Your browser doesn't support javascript.
loading
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro, Giuseppe; Gentile, Francesco; Aimo, Alberto; Januzzi, James L; Richards, A Mark; Lam, Carolyn S P; de Boer, Rudolf A; Meems, Laura M G; Latini, Roberto; Staszewsky, Lidia; Anand, Inder S; Cohn, Jay N; Ueland, Thor; Gullestad, Lars; Aukrust, Pål; Brunner-La Rocca, Hans-Peter; Bayes-Genis, Antoni; Lupón, Josep; Yoshihisa, Akiomi; Takeishi, Yasuchika; Egstrup, Michael; Gustafsson, Ida; Gaggin, Hanna K; Eggers, Kai M; Huber, Kurt; Gamble, Greg D; Ling, Lieng H; Leong, Kui Toh Gerard; Yeo, Poh Shuah Daniel; Ong, Hean Yee; Jaufeerally, Fazlur; Ng, Tze P; Troughton, Richard; Doughty, Robert N; Devlin, Gerry; Lund, Mayanna; Giannoni, Alberto; Passino, Claudio; Emdin, Michele.
Afiliação
  • Vergaro G; Institute of Life Sciences, Scuola Superiore Sant'Anna and Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, via Giuseppe Moruzzi 1, Pisa, 56124, Italy.
  • Gentile F; Cardiology Division, Pisa University Hospital, Pisa, Italy.
  • Aimo A; Institute of Life Sciences, Scuola Superiore Sant'Anna and Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, via Giuseppe Moruzzi 1, Pisa, 56124, Italy.
  • Januzzi JL; Massachusetts General Hospital and Baim Institute for Clinical Research, Boston, MA, USA.
  • Richards AM; Department of Medicine, University of Otago, New Zealand & National University Heart Centre, National University of Singapore, Singapore.
  • Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
  • de Boer RA; University Medical Centre Groningen, Groningen, The Netherlands.
  • Meems LMG; University Medical Centre Groningen, Groningen, The Netherlands.
  • Latini R; Istituto di Ricerche Farmacologiche - "Mario Negri" (IRCCS), Milan, Italy.
  • Staszewsky L; Istituto di Ricerche Farmacologiche - "Mario Negri" (IRCCS), Milan, Italy.
  • Anand IS; University of Minnesota Medical Center, University of Minnesota, Minneapolis, MN, USA.
  • Cohn JN; VA Medical Centre, Minneapolis, MN, USA.
  • Ueland T; University of Minnesota Medical Center, University of Minnesota, Minneapolis, MN, USA.
  • Gullestad L; Oslo University Hospital, Ullevål, Oslo, Norway.
  • Aukrust P; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Brunner-La Rocca HP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Bayes-Genis A; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
  • Lupón J; KG Jebsen Center for Cardiac Research, University of Oslo and Center for Heart Failure Research, Oslo University Hospital, Norway.
  • Yoshihisa A; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Takeishi Y; Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Egstrup M; Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona) and CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.
  • Gustafsson I; Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona) and CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.
  • Gaggin HK; First Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan.
  • Eggers KM; First Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan.
  • Huber K; Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Gamble GD; Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Ling LH; Heart Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Leong KTG; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Yeo PSD; Wilhelminenspital and Sigmund Freud University Medical School, Vienna, Austria.
  • Ong HY; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Jaufeerally F; Department of Cardiology, National University Heart Centre and National University of Singapore, Singapore.
  • Ng TP; Changi General Hospital, Singapore.
  • Troughton R; Tan Tock Seng Hospital, Singapore.
  • Doughty RN; Khoo Teck Puat Hospital, Singapore.
  • Devlin G; Singapore General Hospital, Singapore.
  • Lund M; Department of Cardiology, National University Heart Centre and National University of Singapore, Singapore.
  • Giannoni A; Department of Medicine, University of Otago, New Zealand & National University Heart Centre, National University of Singapore, Singapore.
  • Passino C; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Emdin M; Gisborne Hospital, Gisborne, New Zealand.
ESC Heart Fail ; 9(4): 2084-2095, 2022 08.
Article em En | MEDLINE | ID: mdl-35510529

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Natriurético Encefálico / Proteína 1 Semelhante a Receptor de Interleucina-1 / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Natriurético Encefálico / Proteína 1 Semelhante a Receptor de Interleucina-1 / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article